RXi Pharma (RXII) Earnings
|
Expand Research on RXII
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +12.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -14.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/14/18  |
 |
Q318 | N/A | $0.00 | N/A | N/A | $50K | N/A | N/A | N/A | |
| 8/14/18 |
Q218 | -$0.46 | N/A | N/A | N/A | N/A | N/A |  | | Details | |
| 8/14/18 |
|
Q218 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| 5/10/18 |
|
Q118 | N/A | N/A | N/A | N/A | N/A | = | N/A | N/A | |
| 3/26/18 | |
Q417 | -$0.84 | N/A | N/A | N/A | N/A | = | | | Details |
| 11/8/17 |
|
Q317 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| 8/10/17 |
|
Q217 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| 8/10/17 |
Q217 | -$0.11 | N/A | N/A | N/A | N/A | N/A | | | Details |
